<DOC>
	<DOCNO>NCT02190721</DOCNO>
	<brief_summary>The purpose study evaluate safety , pharmacokinetics , pharmacodynamics , efficacy daily subcutaneous administration 5 μg/kg tbo-filgrastim infant , child adolescent solid tumor without bone marrow involvement .</brief_summary>
	<brief_title>A Study Evaluate 5 μg/kg Tbo-filgrastim Infants , Children Adolescents With Solid Tumors Without Bone Marrow Involvement</brief_title>
	<detailed_description />
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Inclusion : 1 . Male female infant , child adolescent age 1 month &lt; 16 year . 2 . Patients solid tumor without bone marrow involvement , schedule receive myelosuppressive CTX . 3 . Body weight ≥5 kg . 4 . Patients must initial diagnosis histologic proof malignancy . All enrolled subject sign consent CTX regimen know myelotoxic , count expect drop absolute neutrophil count ( ANC ) 0.5 × 109/L least 3 day . These regimen would include least one following : Etoposide doxorubicin ifosfamide cyclophosphamide 5 . ANC platelet count : Patients must ANC &gt; 1 × 109/L platelet count &gt; 100 × 109/L eligible therapy start CTX . 6 . Normal cardiac , renal , hepatic function . 7 . All subject must life expectancy 12 week . 8 . Performance Status : Lansky performance score &gt; 60 ( age 1 &lt; 16 year ) . More criterion may apply , please contact investigator information . Exclusion : 1 . Bone marrow involvement . 2 . Active myelogenous leukemia history myelogenous leukemia . 3 . Previous treatment colonystimulating factor ( granulocyte colonystimulating factor [ GCSF ] , granulocytemacrophage colonystimulating factor , interleukin 11 [ IL11 ] ) less 6 week prior study entry . 4 . History congenital neutropenia cyclic neutropenia . 5 . Pregnant nursing female patient . 6 . Fertile patient agree use highly reliable contraceptive measure Prior bone marrow stem cell transplant , prior radiation ≥25 % bone marrow within 4 week prior first tbofilgrastim dose . 7 . Ongoing active infection history infectious disease within 2 week prior screen visit . 8 . Treatment lithium screening plan study More criterion may apply , please contact investigator information .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Neutropenia</keyword>
</DOC>